Urinary Collagen Fragments Are Significantly Altered in Diabetes: A Link to Pathophysiology

• Published in: PloS one Vol. 5; no. 9; p. e13051
• Main Authors: Maahs, David M., Siwy, Justyna, Argilés, Àngel, Cerna, Marie, Delles, Christian, Dominiczak, Anna F., Gayrard, Nathalie, Iphöfer, Alexander, Jänsch, Lothar, Jerums, George, Medek, Karel, Mischak, Harald, Navis, Gerjan J., Roob, Johannes M., Rossing, Kasper, Rossing, Peter, Rychlík, Ivan, Schiffer, Eric, Schmieder, Roland E., Wascher, Thomas C., Winklhofer-Roob, Brigitte M., Zimmerli, Lukas U., Zürbig, Petra, Snell-Bergeon, Janet K.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 28.09.2010; Public Library of Science (PLoS)
• Subjects: Adult; Analysis; Biology; Biomarkers; Biomarkers - urine; Capillary electrophoresis; Cohort Studies; Collagen; Collagen (type I); Collagen - urine; Diabetes; Diabetes and Endocrinology; Diabetes and Endocrinology/Type 1 Diabetes; Diabetes and Endocrinology/Type 2 Diabetes; Diabetes mellitus; Diabetes Mellitus, Type 1 - physiopathology; Diabetes Mellitus, Type 1 - urine; Diabetes Mellitus, Type 2 - physiopathology; Diabetes Mellitus, Type 2 - urine; Extracellular matrix; Extracellular Matrix - chemistry; Female; Fragments; Humans; Hyperglycemia; Immune response; Inflammation; Insulin resistance; Internal medicine; Kidney diseases; Laboratories; Male; Mass Spectrometry; Medicine; Metabolism; Middle Aged; Nephrology; Pathogenesis; Patients; Peptides; Prostate cancer; Proteins; Proteomics; Renal function; Scientific imaging; Spectrometry; Type 2 diabetes; Urine; Variance analysis; United States > US; Czech Republic; Colorado
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0013051

The pathogenesis of diabetes mellitus (DM) is variable, comprising different inflammatory and immune responses. Proteome analysis holds the promise of delivering insight into the pathophysiological changes associated with diabetes. Recently, we identified and validated urinary proteomics biomarkers for diabetes. Based on these initial findings, we aimed to further validate urinary proteomics biomarkers specific for diabetes in general, and particularity associated with either type 1 (T1D) or type 2 diabetes (T2D). Therefore, the low-molecular-weight urinary proteome of 902 subjects from 10 different centers, 315 controls and 587 patients with T1D (n = 299) or T2D (n = 288), was analyzed using capillary-electrophoresis mass-spectrometry. The 261 urinary biomarkers (100 were sequenced) previously discovered in 205 subjects were validated in an additional 697 subjects to distinguish DM subjects (n = 382) from control subjects (n = 315) with 94% (95% CI: 92-95) accuracy in this study. To identify biomarkers that differentiate T1D from T2D, a subset of normoalbuminuric patients with T1D (n = 68) and T2D (n = 42) was employed, enabling identification of 131 biomarker candidates (40 were sequenced) differentially regulated between T1D and T2D. These biomarkers distinguished T1D from T2D in an independent validation set of normoalbuminuric patients (n = 108) with 88% (95% CI: 81-94%) accuracy, and in patients with impaired renal function (n = 369) with 85% (95% CI: 81-88%) accuracy. Specific collagen fragments were associated with diabetes and type of diabetes indicating changes in collagen turnover and extracellular matrix as one hallmark of the molecular pathophysiology of diabetes. Additional biomarkers including inflammatory processes and pro-thrombotic alterations were observed. These findings, based on the largest proteomic study performed to date on subjects with DM, validate the previously described biomarkers for DM, and pinpoint differences in the urinary proteome of T1D and T2D, indicating significant differences in extracellular matrix remodeling.